Certara Inc., the Princeton-based biosimulation company, has named a new chief commercial officer, it announced Tuesday.
Drayton T. Virkler has been named to the newly created position, in which he will drive the company’s global commercial strategy and expand its business development team, according to a news release.
“I am pleased to welcome Drayton as our new chief commercial officer,” CEO William F. Feehery said in a prepared statement. “His role will be vital to advancing our business growth strategy of global expansion and deepening our partnerships with biopharmaceutical clients.
Read more from ROI-NJ:
“Drayton’s extensive leadership experience and commercial knowledge will be invaluable as we continue increasing adoption of biosimulation and other technologies to transform the drug development process.”
Virkler, who has more than 20 years of experience in the pharmaceutical industry, was most recently vice president and global head of sales for Iqvia’s Real World Solutions Global Business Unit.